FDA Accepts Review of Drug Application of Roflumilast Foam for Seborrheic Dermatitis
It was announced by Arcutis Biotherapeutics that the US Food and Drug Administration had accepted for review their NDA for roflumilast foam 0.3%.
Stay updated with breaking news from Individuals Aged. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
It was announced by Arcutis Biotherapeutics that the US Food and Drug Administration had accepted for review their NDA for roflumilast foam 0.3%.
Researchers conducted a population-based cohort study among 12 to 17-year-old adolescents in Ontario, Canada, to estimate the incidence of myocarditis or pericarditis after BNT162b2 vaccination.
Hastings Prince Edward Public Health has released an update about COVID-19 vaccination clinics. The local heal...
To embed, copy and paste the code into your website or blog: Encouraging signs continue in the COVID-19 response, as the federal government looks to fine-tune the vaccine distribution process and additional vaccine options seem poised to enter the market. More People Vaccinated Than the Number of Infected As of yesterday, 27.9 million Americans had received at least one dose of the Pfizer or Moderna vaccine. This passes the total number of COVID-19 cases in the United States, which is 26.5 million. Israel, the United Kingdom, and the United Arab Emirates have also crossed the same threshold. ...
To embed, copy and paste the code into your website or blog: The country breathed a collective sigh of relief last week when the first doses of the Pfizer-BioNtech COVID-19 vaccine were shipped out to all 50 states. Following shortly behind, the first doses of the Moderna vaccine were shipped out this week. Healthcare workers and long-term care residents were given priority to receive these first doses. But Americans will need to get into the queue for the later doses. With vaccine supplies limited, where will your employees fall in the line of priority? The answer to this question is not eas...